YICHANG HUMANWELL FDA Approval ANDA 212033

ANDA 212033

YICHANG HUMANWELL

FDA Drug Application

Application #212033

Application Sponsors

ANDA 212033YICHANG HUMANWELL

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL220MG0NAPROXEN SODIUMNAPROXEN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2019-08-30STANDARD

Submissions Property Types

ORIG1Null15

CDER Filings

YICHANG HUMANWELL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212033
            [companyName] => YICHANG HUMANWELL
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"220MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/30\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"02\/29\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-02-29
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.